Page last updated: 2024-08-17

adenosine monophosphate and Aneurysm, Anterior Cerebral Artery

adenosine monophosphate has been researched along with Aneurysm, Anterior Cerebral Artery in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Aghaebrahim, A; Aguilar-Salinas, P; Clarençon, F; Cortez, GM; Dabus, G; Elhorany, M; Grigoryan, M; Hanel, RA; Linfante, I; Mirza, S; Monteiro, A; Murtaza, Y; Sauvageau, E; Sourour, N1
Dagois, S; De Mesmay, M; Devys, JM; Dupont, C; Godier, A; Mazighi, M; Mesnil, M; Thion, LA1
Abdennour, L; Bernard, R; Carpentier, A; Clarençon, F; Degos, V; Drir, M; Godier, A; Lenck, S; Mathout, J; Premat, K; Shotar, E; Sourour, N; Taylor, G1

Other Studies

3 other study(ies) available for adenosine monophosphate and Aneurysm, Anterior Cerebral Artery

ArticleYear
The use of cangrelor in neurovascular interventions: a multicenter experience.
    Neuroradiology, 2021, Volume: 63, Issue:6

    Topics: Adenosine Monophosphate; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Treatment Outcome

2021
Bridging antiplatelet therapy with cangrelor in patients with recent intracranial stenting undergoing invasive procedures: a prospective case series.
    British journal of anaesthesia, 2019, Volume: 123, Issue:1

    Topics: Adenosine Monophosphate; Aspirin; Brain; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Intracranial Thrombosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents

2019
Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms.
    Clinical neuroradiology, 2020, Volume: 30, Issue:3

    Topics: Adenosine Monophosphate; Aneurysm, Ruptured; Aspirin; Cerebral Angiography; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Stents

2020